Sign In
Buy ELVN
$36.03
+0.510 (+1.44%)
At Close: Jun 03, 2026
Imara: Potential Liquidation
03:06pm, Thursday, 29'th Sep 2022
Imara has announced strategic alternatives and has announced the sale its key asset. It now trades 37% below its Pro Forma net cash levels and a liquidation would be ideal.
Has IMARA (IMRA) Outpaced Other Medical Stocks This Year?
11:17am, Friday, 16'th Sep 2022
Here is how IMARA Inc. (IMRA) and Viracta (VIRX) have performed compared to their sector so far this year.
3 High Volume Penny Stocks To Watch Before Next Week
06:00am, Friday, 09'th Sep 2022
Here's what you need to know about buying penny stocks on September 9th, 2022 The post 3 High Volume Penny Stocks To Watch Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Infor
10 Top Penny Stocks With Unusual Options Activity This Week
03:27pm, Thursday, 08'th Sep 2022
Penny stocks to watch today with unusual options action. The post 10 Top Penny Stocks With Unusual Options Activity This Week appeared first on Penny Stocks to Buy, Picks, News and Information | Penny
Looking for Popular Penny Stocks to Buy? 3 to Watch Now
06:00am, Thursday, 08'th Sep 2022
Which penny stocks are you buying today? The post Looking for Popular Penny Stocks to Buy?
5 Top Penny Stocks With Unusual Options Activity Today
11:52am, Wednesday, 07'th Sep 2022
Penny stocks to watch with unusual options activity today. The post 5 Top Penny Stocks With Unusual Options Activity Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
What Makes IMARA Inc. (IMRA) a New Buy Stock
01:33pm, Thursday, 19'th May 2022
IMARA Inc. (IMRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read Why Imara Shares Are Falling Today
10:13am, Tuesday, 05'th Apr 2022
Imara Inc (NASDAQ: IMRA) shares are falling after interim analyses of its Ardent Phase 2b trial of tovinontrine (IMR-687) in sickle cell disease (SCD) and Forte Phase 2b trial in beta-thalassemia.�
Imara (IMRA) CEO, Rahul Ballal on Q4 2021 Results - Earnings Call Transcript
11:06am, Tuesday, 15'th Mar 2022
Imara (IMRA) CEO, Rahul Ballal on Q4 2021 Results - Earnings Call Transcript
7 Biotech Stocks With Key Catalysts in March
06:24am, Wednesday, 09'th Mar 2022
These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways. The post 7 Biotech Stocks With Key Catalysts in March appeared first on Invest
Imara to Webcast Conference Call of Full Year 2021 Financial Results and Business Highlights
07:00am, Tuesday, 08'th Mar 2022
BOSTON, March 08, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffer
Best Penny Stocks To Buy? 3 To Watch With Insider Buying In February
01:23pm, Monday, 21'st Feb 2022
Insiders are scooping up these penny stocks in February. The post Best Penny Stocks To Buy?
Imara to Present at 11th Annual SVB Leerink Global Healthcare Conference
07:00am, Thursday, 10'th Feb 2022
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients sufferi
Imara To Start Testing Tovinontrine In Heart Failure Patients
11:03am, Tuesday, 25'th Jan 2022
The FDA signed off Imara Inc's (NASDAQ: IMRA) investigational new drug (IND) application for tovinontrine (IMR-687) in heart failure with preserved ejection fraction (HFpEF). The Company plans to i
Imara to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
07:00am, Wednesday, 05'th Jan 2022
BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat subjects sufferi
